Beijing Friendship Hospital Metabolic Surgery Database
Beijing Friendship Hospital Metabolic Surgery Clinical Database
Beijing Friendship Hospital
3,000 participants
Dec 1, 2017
OBSERVATIONAL
Conditions
Summary
Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.
Eligibility
Inclusion Criteria1
- be able to receive metabolic surgery (LSG or LRYGB)
Exclusion Criteria1
- can not be able to understand and willing to participate in this registry with signature
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03520699